Surge Reconstruction in the Western North Pacific

A daily maximum storm surge reconstruction for 160 tide gauge locations in the Western North Pacifi

surgeReconstruction_WNP_Scripts

Code used for data pre-processing, model training and validatio

DataSheet_1_Variations and Environmental Controls of Primary Productivity in the Amundsen Sea.docx

The Amundsen Sea is one of the regions with the highest primary productivity in the Antarctic. To better understand the role of the Southern Ocean in the global carbon cycle and in climate regulation, a better understanding of the variations and environmental controls of primary productivity is needed. Using cluster analysis, the Amundsen Sea was divided into nine bioregions. The biophysical differences among bioregions enhanced confidence to identify priorities and regions to study the temporal and spatial variations in primary production. Four nearshore bioregions with high net primary productivity or rapidly increasing rates were selected to analyze temporal and spatial variations in primary productivity in the Amundsen Sea. Due to changes in net solar radiation and sea ice, primary production had significant seasonal variation in these four bioregions. The phenology had changed at two bioregions (6 and 7), which has the third and fourth highest primary production, due to changes in the dissolved iron. Annual primary production showed increasing trends in these four bioregions, and it was significant at three bioregions. The variation in primary production in the bioregion (9), which has the highest primary production, was mainly affected by variations in sea surface temperatures. In the bioregion (8), which has the second-highest primary production, the primary production was significantly positively correlated with sea surface temperature and significantly negatively correlated with sea ice thickness. The long-term changes of primary productivity in bioregions 6 and 7 were thought to be related to changes in the dissolved iron, and dissolved iron was the limiting factor in these two bioregions. Bioregionalization not only disentangles multiple factors that control the spatial differences, but also disentangles limiting factors that affect the phenology, decadal and long-term changes in primary productivity.</p

Additional file 1: of Whole-exome sequencing identifies a novel missense variant within LOXHD1 causing rare hearing loss in a Chinese family

Supplementary Materials and Tables. (a) The process of whole-exome sequencing (WES) analysis. (b) Table S1. Filtering process of WES analysis in our study. (c) Table S2. Candidate gene and variant identified by trio-WES. (d) Table S3. Variants validated by Sanger sequencing. (DOC 59 kb

Image_2_Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis.tif

Background: Aberrant hypermethylation of the Septin 9 (SEPT9) is an early event in several human cancers, and increasing studies have reported good performance of methylated SEPT9 (mSEPT9) in cancer diagnosis. Recent studies further focused on its value in cancer prognosis, but results are not clearly elucidated.Methods: A comprehensive search to identify relevant studies about the association between mSEPT9 and cancer prognosis was conducted through the EMBASE, PubMed, and Web of Science databases (up to January 2019). The main outcomes were overall survival (OS) and disease-free survival (DFS). The hazard ratio (HR) and 95% confidence interval (CI) for OS and DFS were extracted from each included study and pooled using a random-effects model.Results: Ten eligible studies comprising 1,266 cancer patients were included. Results demonstrated that mSEPT9 was associated with poor OS (HR = 2.07, 95% CI = 1.40–3.06). Specially, mSEPT9 detected in preoperative plasma predicted worse OS in cancer patients (HR = 3.25, 95% CI = 1.93–5.48). In addition, we also identified a significant association of mSEPT9 with decreased DFS of cancer (HR = 3.24, 95% CI = 1.81–5.79).Conclusion: Our meta-analysis supports that mSEPT9 is associated with reduced OS and DFS in cancer patients. Moreover, detection of mSEPT9 using plasma appears to be a convenient and promising way to predict long-term survival of cancer patients.</p

Table_1_Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis.doc

Background: Aberrant hypermethylation of the Septin 9 (SEPT9) is an early event in several human cancers, and increasing studies have reported good performance of methylated SEPT9 (mSEPT9) in cancer diagnosis. Recent studies further focused on its value in cancer prognosis, but results are not clearly elucidated.Methods: A comprehensive search to identify relevant studies about the association between mSEPT9 and cancer prognosis was conducted through the EMBASE, PubMed, and Web of Science databases (up to January 2019). The main outcomes were overall survival (OS) and disease-free survival (DFS). The hazard ratio (HR) and 95% confidence interval (CI) for OS and DFS were extracted from each included study and pooled using a random-effects model.Results: Ten eligible studies comprising 1,266 cancer patients were included. Results demonstrated that mSEPT9 was associated with poor OS (HR = 2.07, 95% CI = 1.40–3.06). Specially, mSEPT9 detected in preoperative plasma predicted worse OS in cancer patients (HR = 3.25, 95% CI = 1.93–5.48). In addition, we also identified a significant association of mSEPT9 with decreased DFS of cancer (HR = 3.24, 95% CI = 1.81–5.79).Conclusion: Our meta-analysis supports that mSEPT9 is associated with reduced OS and DFS in cancer patients. Moreover, detection of mSEPT9 using plasma appears to be a convenient and promising way to predict long-term survival of cancer patients.</p

Multiobjective Evaluation of Amine-Based Absorbents for SO₂ Capture Process Using the p<i>K</i>_a Mathematical Model

The screening of high-efficiency and low-energy consumption absorbents is critical for capturing SO2. In this study, absorbents with better performance are screened based on mechanism, model, calculation, verification, and analysis methods. The acidity coefficient (pKa) values of ethylenediamine (EDA), piperazine (PZ), 1-(2-hydroxyethyl)­piperazine (HEP), 1,4-bis­(2-hydroxyethyl)­piperazine (DIHEP), and 1-(2-hydroxyethyl)-4-(2-hydroxypropyl)­piperazine (HEHPP) are calculated by quantum chemical methods. A mathematical model of the SO2 cyclic absorption capacity per amine (αc) in the amine-based SO2 capture process is built based on the electroneutrality of the solution. Another model of desorption reaction heat (Qdes) is also built based on the van’t Hoff equation. Correspondingly, αc and Qdes of the above five diamines are calculated and verified with the experimental data. The results show that αc of the diamine changes with the increase in the pKa value, and the increase in the pKa value directly leads to changes in Qdes. The order of αc of the above five diamines is EDA > PZ > HEHPP > HEP > DIHEP, and the order of Qdes is EDA > PZ > HEHPP > DIHEP > HEP. The multiobjective analysis between αc and Qdes suggests that it is not advisable to simply pursue a higher αc while ignoring Qdes. The compound quaternary system absorbent has a wider range of αc than the single ternary absorbent, which is the direction of absorbent development. This study is expected to strengthen absorbent screening for the amine-based SO2 capture process from flue gas

DataSheet_1_Understanding the compound marine heatwave and low-chlorophyll extremes in the western Pacific Ocean.docx

The western Pacific Ocean is the global center for marine biodiversity, with high vulnerability to climate change. A better understanding of the spatiotemporal characteristics and potential drivers of compound marine heatwaves (MHWs) and low-chlorophyll (LChl) extreme events is essential for the conservation and management of local marine organisms and ecosystems. Here, using daily satellite sea surface temperature and model-based chlorophyll concentration, we find that the climatological spatial distribution of MHW-LChl events in total days, duration, and intensity exhibits heterogeneous distributions. The southwest sections of the South China Sea (WSCS) and Indonesian Seas are the hotspots for compound events, with total MHW-LChl days that are more than 2.5 times higher than in the other sub-regions. Notably, there is a trend toward more frequent (> 4.2 d/decade), stronger (> 0.5), and longer-lasting (> 1.4 d/decade) MHW-LChl occurrences in the WSCS. The occurrence of compound MHW-LChl extremes exhibits remarkable seasonal differences, with the majority of these events transpiring during winter. Moreover, there are generally statistically significant increasing trends in MHW-LChl events for all properties on both seasonal and inter-annual timescales. Furthermore, we reveal that the total days of compound MHW-LChl extremes are strongly modulated by large-scale climate modes such as the El Niño-Southern Oscillation and Dipole Mode Index. Overall, pinpointing MHW-LChl hotspots and understanding their changes and drivers help vulnerable communities in better preparing for heightened and compounded risks to marine organism and ecosystems under climate change.</p

Table_2_Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis.doc

Background: Aberrant hypermethylation of the Septin 9 (SEPT9) is an early event in several human cancers, and increasing studies have reported good performance of methylated SEPT9 (mSEPT9) in cancer diagnosis. Recent studies further focused on its value in cancer prognosis, but results are not clearly elucidated.Methods: A comprehensive search to identify relevant studies about the association between mSEPT9 and cancer prognosis was conducted through the EMBASE, PubMed, and Web of Science databases (up to January 2019). The main outcomes were overall survival (OS) and disease-free survival (DFS). The hazard ratio (HR) and 95% confidence interval (CI) for OS and DFS were extracted from each included study and pooled using a random-effects model.Results: Ten eligible studies comprising 1,266 cancer patients were included. Results demonstrated that mSEPT9 was associated with poor OS (HR = 2.07, 95% CI = 1.40–3.06). Specially, mSEPT9 detected in preoperative plasma predicted worse OS in cancer patients (HR = 3.25, 95% CI = 1.93–5.48). In addition, we also identified a significant association of mSEPT9 with decreased DFS of cancer (HR = 3.24, 95% CI = 1.81–5.79).Conclusion: Our meta-analysis supports that mSEPT9 is associated with reduced OS and DFS in cancer patients. Moreover, detection of mSEPT9 using plasma appears to be a convenient and promising way to predict long-term survival of cancer patients.</p

Image_1_Hypermethylation of the SEPT9 Gene Suggests Significantly Poor Prognosis in Cancer Patients: A Systematic Review and Meta-Analysis.tif

Background: Aberrant hypermethylation of the Septin 9 (SEPT9) is an early event in several human cancers, and increasing studies have reported good performance of methylated SEPT9 (mSEPT9) in cancer diagnosis. Recent studies further focused on its value in cancer prognosis, but results are not clearly elucidated.Methods: A comprehensive search to identify relevant studies about the association between mSEPT9 and cancer prognosis was conducted through the EMBASE, PubMed, and Web of Science databases (up to January 2019). The main outcomes were overall survival (OS) and disease-free survival (DFS). The hazard ratio (HR) and 95% confidence interval (CI) for OS and DFS were extracted from each included study and pooled using a random-effects model.Results: Ten eligible studies comprising 1,266 cancer patients were included. Results demonstrated that mSEPT9 was associated with poor OS (HR = 2.07, 95% CI = 1.40–3.06). Specially, mSEPT9 detected in preoperative plasma predicted worse OS in cancer patients (HR = 3.25, 95% CI = 1.93–5.48). In addition, we also identified a significant association of mSEPT9 with decreased DFS of cancer (HR = 3.24, 95% CI = 1.81–5.79).Conclusion: Our meta-analysis supports that mSEPT9 is associated with reduced OS and DFS in cancer patients. Moreover, detection of mSEPT9 using plasma appears to be a convenient and promising way to predict long-term survival of cancer patients.</p